A Phase 1, Open-Label Study to Investigate the Effect of Albuterol (Salbutamol) and Fluticasone on the Pharmacokinetics of Inhaled Technosphere® Insulin Inhalation Powder in Healthy Subjects.

Trial Profile

A Phase 1, Open-Label Study to Investigate the Effect of Albuterol (Salbutamol) and Fluticasone on the Pharmacokinetics of Inhaled Technosphere® Insulin Inhalation Powder in Healthy Subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 12 Jun 2012

At a glance

  • Drugs Fluticasone propionate; Insulin; Salbutamol
  • Indications Asthma; Chronic obstructive pulmonary disease; Type 1 diabetes mellitus; Type 2 diabetes mellitus
  • Focus Pharmacokinetics
  • Sponsors MannKind Corporation
  • Most Recent Events

    • 12 Jun 2012 Actual patient number is 13 according to ClinicalTrials.gov.
    • 22 May 2009 Actual end date (Oct 2008) added as reported by ClinicalTrials.gov.
    • 22 May 2009 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top